Cirius Therapeutics Overview
- Founded
- 2015

- Status
- Private
- Employees
- 11

- Latest Deal Type
- IPO
- (Cancelled)
- Latest Deal Amount
- $86.2M

- Investors
- 5
Cirius Therapeutics General Information
Description
Developer of an insulin sensitizer drug designed for the treatment of nonalcoholic liver disease. The company's sensitizer drug is used to treat nonalcoholic steatohepatitis which is characterized by buildup of fat and inflammation in the liver, may be accompanied by fibrosis and can progress to life-threatening cirrhosis or liver cancer, enabling healthcare providers to treat patients of the liver and metabolic diseases and avoid recurrence of nonalcoholic steatohepatitis.
Contact Information
- 12651 High Bluff Drive
- Suite 150
- San Diego, CA 92130
- United States
Cirius Therapeutics Timeline
Cirius Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. IPO | 20-Dec-2019 | $86.2M | Cancelled | Generating Revenue | ||
4. Early Stage VC (Series A3) | 10-May-2019 | 00.00 | 000.00 | 00000 | Completed | Generating Revenue |
3. Early Stage VC (Series A3) | 23-Aug-2018 | 000 | 000.00 | 00000 | Completed | Startup |
2. Early Stage VC (Series A2) | 10-Apr-2017 | $40M | $56.4M | 0000 | Completed | Startup |
1. Early Stage VC (Series A1) | 19-May-2016 | $16.4M | $16.4M | 000.00 | Completed | Startup |
Cirius Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A3 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series A2 | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A1 | 17,069,451 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 17.25% |
Cirius Therapeutics Comparisons
Industry
00000 00
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCirius Therapeutics Competitors (41)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Tioga Pharmaceuticals | Venture Capital-Backed | San Diego, CA | 00 | 0000 | 000000 - 000 | 0000 |
0000000000 0000000 | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | 00 | 00000 | 00000000000 | 00000 |
000000000(00000000 | Formerly VC-backed | New York, NY | 000 | 00000 | 000000 - 000 | 00000 |
0000 000000000000 | Venture Capital-Backed | London, United Kingdom | 00 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Corporation | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
Cirius Therapeutics Executive Team (7)
Cirius Therapeutics Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Estes Ph.D | Frazier Healthcare Partners | Board Member | 000 0000 |
David Van Andel | Cirius Therapeutics | Board Member | 000 0000 |
Dennis Fenton Ph.D | Self | Board Member | 000 0000 |
Elaine Sun | Self | Board Member | 000 0000 |
Michael Jandernoa | Self | Board Member | 000 0000 |
Cirius Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCirius Therapeutics Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Adams Street Partners | Fund of Funds | Minority | 000 0000 | 000000 0 | |
Frazier Healthcare Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Hopen Life Science Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Novo Holdings | Venture Capital | Minority | 000 0000 | 000000 0 | |
Renaissance Venture Capital Fund | Fund of Funds | Minority | 000 0000 | 000000 0 |